C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2009
12/30/2009	EP1678161B1 Thioether-substituted benzamides as inhibitors of factor xa
12/30/2009	EP1663976B1 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents
12/30/2009	EP1608352B1 Polyamine compounds for treating chemokine receptor mediated diseases
12/30/2009	CN101616896A Tricyclic compounds and their use as glucocorticoid receptor modulators
12/30/2009	CN101616895A Compounds and compositions as protein kinase inhibitors
12/30/2009	CN101613316A Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/30/2009	CN101613315A Cyclometalated platinum complexes liquid crystal polarized luminescent material and application thereof
12/30/2009	CN101613307A Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
12/30/2009	CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/30/2009	CN100575330C Novel compounds
12/30/2009	CN100574880C Magnesium Cobalt base catalyst for synthesizing pyridine base from formaldehyde, aldehyde and ammonia
12/30/2009	CA2729327A1 Organic compounds
12/30/2009	CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
12/30/2009	CA2729108A1 Organic compounds
12/30/2009	CA2728806A1 Squaric acid derivatives as inhibitors of the nicotinamide phosphoribosyltransferase
12/30/2009	CA2728767A1 Alkynyl alcohols as kinase inhibitors
12/30/2009	CA2728511A1 Sulfonamide compounds or salts thereof
12/30/2009	CA2727573A1 Diaryl compounds and uses thereof
12/30/2009	CA2727078A1 Sulfoximinamide compounds for combating animal pests
12/29/2009	US7638648 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
12/29/2009	US7638635 Using alkylmetal reagents for directed metalation of azaaromatics
12/29/2009	US7638632 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties
12/29/2009	US7638531 use in treating inflammatory diseases, allergic conditions, diabetes, obesity, an obesity-related disorder, metabolic syndrome, a cognition deficit disorder, cardiovascular and central nervous system disorders
12/29/2009	US7638514 Agriculture
12/29/2009	CA2477851C Small molecule entry inhibitors
12/29/2009	CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
12/29/2009	CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors
12/29/2009	CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/29/2009	CA2345369C Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
12/24/2009	US20090318703 Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient
12/24/2009	US20090318511 Selective hydroxamate based mmp inhibitors
12/24/2009	US20090318509 Oxime Derivatives as Inhibitors of Macrophage Migration Inhibitory Factor
12/24/2009	US20090318506 Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
12/24/2009	US20090318503 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
12/24/2009	US20090318497 Substituted pyridylmethyl bicycliccarboxyamide compounds
12/24/2009	US20090318490 Compounds and methods for promoting smoking cessation
12/24/2009	US20090318473 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
12/24/2009	US20090318466 Compounds useful as pesticides
12/24/2009	US20090318455 Compounds and methods for treating inflammatory and fibrotic disorders
12/24/2009	US20090318452 INHIBITORS OF p38
12/23/2009	WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses
12/23/2009	WO2009154190A1 Pyridone compound
12/23/2009	WO2009153721A1 Nicotinamide derivatives
12/23/2009	WO2009153720A1 Nicotinamide derivatives
12/23/2009	WO2009153272A2 Method for the iodination of aromatic and/or heteroaromatic compounds
12/23/2009	WO2009153214A1 Process for the manufacture of an intermediate in the synthesis of dabigatran
12/23/2009	WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	WO2009152906A2 Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions
12/23/2009	WO2009152868A1 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands
12/23/2009	WO2009126863A3 Pyridyl inhibitors of hedgehog signalling
12/23/2009	WO2009066060A3 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use
12/23/2009	EP2135620A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
12/23/2009	EP2134690A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
12/23/2009	EP2134688A1 Fluorinated derivatives of deferiprone
12/23/2009	EP2134687A1 Piperazine and piperidine mglur5 potentiators
12/23/2009	EP2134175A1 Inhibitors of akt activity
12/23/2009	EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
12/23/2009	EP1817309B1 Acetamide compounds as fungicides
12/23/2009	EP1791811B1 Aminoalcohol derivatives
12/23/2009	EP1709037B1 Hiv protease inhibiting sulfonamides
12/23/2009	EP1356816B1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
12/23/2009	EP1259487B1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
12/23/2009	CN101611008A Modulators of C3A receptor and methods of use thereof
12/23/2009	CN101611007A Novel JNK inhibitors
12/23/2009	CN101611006A Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide
12/23/2009	CN101611005A Substituted acetophenones useful as PDE4 inhibitors
12/23/2009	CN101611004A Process for the preparation of 2-substituted-5-(1-alkylthio) alkylpyridines
12/23/2009	CN101607936A Gimeracil crystal form and preparation method thereof
12/23/2009	CN101607935A Method for synthesizing Gallant-Super by adopting pre-etherification method and taking N, N-dimethyl acetamide as solvent
12/23/2009	CN101607934A 2-ammonia methyl-pyridine nickel composition, preparation method and application thereof
12/23/2009	CN100572385C Salts comprising cyanoborate anions
12/23/2009	CA2728156A1 Pyridone compounds
12/23/2009	CA2728057A1 Process for the manufacture of an intermediate in the synthesis of dabigatran
12/23/2009	CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	CA2725481A1 Nicotinamide derivatives
12/23/2009	CA2724998A1 Nicotinamide derivatives
12/22/2009	US7635674 insulin and carrieres, a second pharmaceutical composition containing O-(3-piperidino-2-hydroxy-1-propyl)nicotinic amidoxime ( BGP-15) and carriers; prediabetic state, metabolic X-syndrome, insulin sensitivity, glucose tolerance, dislipidemia or diabetes mellitus
12/22/2009	CA2452558C A synergistic pharmaceutical combination for the prevention or treatment of diabetes
12/22/2009	CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
12/22/2009	CA2326529C 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide
12/17/2009	WO2009152168A2 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
12/17/2009	WO2009152142A1 Sulfonate salts of flupirtine
12/17/2009	WO2009152082A1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors
12/17/2009	WO2009151039A1 Organic electroluminescent element
12/17/2009	WO2009150381A2 Azacarboline derivatives, preparation method thereof and therapeutic use of same
12/17/2009	WO2009119980A3 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
12/17/2009	WO2009092590A3 2 -cyano phenyl sulfonamide derivatives useful as pesticides
12/17/2009	WO2009068284A3 Process for the stereoselective reduction of ketoimines catalysed by trichlorosilane
12/17/2009	US20090312424 Aromatic prodrugs of propofol, compositions and uses thereof
12/17/2009	US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009	US20090312355 Non-Flushing Niacin Analogues, and Methods of Use Thereof
12/17/2009	US20090312354 DHA Esters and Use Thereof In Treatment and Prevention of Cardiovascular Disease
12/17/2009	US20090312328 Sulfonamide compound or salt thereof
12/17/2009	US20090312314 Heteroaromatic monoamides as orexinin receptor antagonists
12/17/2009	CA2727684A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor
12/17/2009	CA2725093A1 Azacarboline derivatives, preparation method thereof and therapeutic us of same
12/16/2009	EP2133342A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof
12/16/2009	EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
12/16/2009	EP2133338A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine
12/16/2009	EP2133337A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine

1 ... 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 ... 633